Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,761
Closed -$393K 1091
2022
Q1
$393K Sell
2,761
-14,039
-84% -$1.99M 0.03% 642
2021
Q4
$2.96M Buy
+16,800
New +$2.81M 0.23% 158
2021
Q1
Sell
-2,645
Closed -$313K 845
2020
Q4
$313K Buy
+2,645
New +$309K 0.02% 536
2020
Q3
Sell
-3,505
Closed -$374K 815
2020
Q2
$374K Buy
3,505
+791
+29% +$73.5K 0.03% 478
2020
Q1
$217K Sell
2,714
-496
-15% -$44.3K 0.02% 548
2019
Q4
$284K Buy
+3,210
New +$277K 0.02% 557
2018
Q2
Sell
-65,646
Closed -$3.42M 556
2018
Q1
$3.42M Sell
65,646
-9,754
-13% -$534K 0.12% 204
2017
Q4
$3.77M Buy
75,400
+14,000
+23% +$682K 0.11% 226
2017
Q3
$2.68M Buy
61,400
+19,000
+45% +$739K 0.09% 250
2017
Q2
$1.53M Buy
42,400
+12,824
+43% +$407K 0.06% 287
2017
Q1
$785K Buy
29,576
+16,876
+133% +$412K 0.04% 340
2016
Q4
$267K Buy
+12,700
New +$242K 0.02% 446

Other funds holding NOVT

PDT Partners's NOVT Position: Q2 2022 in Review

PDT Partners sold out of Novanta (NOVT) in Q2 2022, closing a stake of 2,761 shares — an estimated $393K sold.

PDT Partners first reported a position in NOVT in Q4 2016 and held it in 12 quarters. The position peaked at $3.77M in Q4 2017. 222 funds tracked by Wall St. Rank hold NOVT as of Q2 2022.

  • PDT Partners reported no remaining Novanta position as of Q2 2022 after selling out during the quarter.
  • PDT Partners sold 2,761 Novanta shares in Q2 2022, an estimated $393K.
  • PDT Partners first reported a position in Novanta in Q4 2016 and held it in 12 quarters.
  • PDT Partners's Novanta position peaked at $3.77M in Q4 2017.
  • 222 funds tracked by Wall St. Rank held Novanta as of Q2 2022.

Based on PDT Partners's 13F filing for Q2 2022, filed 15 Aug 2022.